Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
US7005538B1 · kind B1 · utility
5Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2000 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Feb 11, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyrodism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.